Align Partners Sends Second Public Shareholder Letter to Coway, Urging Announcement of Revised Value-up Plan by January 30, 2026

  • Align identifies an inefficient capital structure and a sharp contraction in shareholder returns as core drivers of Coway’s undervaluation

• The letter outlines seven key measures to strengthen capital allocation and governance

• Align urges Coway to announce a more concrete and enhanced Value-up Plan by January 30, 2026

 

(BUSINESS WIRE) -- Align Partners Capital Management Inc. (“Align Partners”), a shareholder of Coway Co., Ltd. (“Coway”) since 2023 holding more than 4% of the Company’s outstanding shares through funds it manages or advises, announced that it has sent a second public shareholder letter to Coway’s Board of Directors. The letter calls for measures to address the company’s chronic undervaluation and enhance shareholder value. Align Partners has requested that Coway announce a revised corporate Value-up Plan reflecting these proposals by January 30, 2026.

In the letter, Align Partners assessed Coway’s February 2025 plan as insufficient to address Coway’s persistent undervaluation and urged the Board to incorporate seven measures: (1) clear mid-to-long-term valuation and ROE targets with execution plans; (2) clarified and strengthened target capital structure policy; (3) updated shareholder return policy reflecting both the target capital structure policy and new dividend income tax separation regime; (4) enhanced investor relations disclosures; (5) board independence reforms; (6) measures to address conflicts of interest between controlling and minority shareholders; and (7) stronger alignment between executive compensation and share price performance.

Despite Coway’s strong operating performance and leading market position, the Company’s valuation remains meaningfully below historical levels. Align Partners attributes this undervaluation primarily to an inefficient capital structure and reduced shareholder returns following Netmarble’s acquisition. Align Partners also noted that Coway has financed finance lease driven working capital growth largely through retained earnings accumulated by scaling back shareholder returns, rather than through lower-cost debt. These capital allocation decisions, according to Align Partners, reflect deeper structural governance issues, including insufficient board independence.

Changhwan Lee, CEO of Align Partners, stated that the second public shareholder letter is intended to encourage Coway to establish a structural framework that enables a return to normalized valuation levels and supports sustainable long-term growth.

More information is available at www.alignpartnerscap.com

About Align Partners

Align Partners is a Korea-focused investment firm led by CEO Changhwan Lee, leveraging private equity and investment banking expertise to drive sustainable growth and address the “Korea discount.”

https://www.alignpartnerscap.com/en/

View source version on businesswire.com: https://www.businesswire.com/news/home/20251215625655/en/

Permalink

https://www.aetoswire.com/en/news/1512202551757

Contacts

Wooseok Choi

coway_valueup@alignpartnerscap.com

+82-2-6956-8033

Applications now open for the 5th cycle of the Mohammed bin Rashid Al Maktoum Global Water Award

 HE Saeed Mohammed Al Tayer, Chairman of the Board of Trustees of the UAE Water Aid Foundation (Suqia UAE), announced the opening of applications for the 5th cycle of the Mohammed bin Rashid Al Maktoum Global Water Award, offering USD 1 million in prizes. The award seeks to inspire innovative, clean energy–powered solutions for water production, distribution, storage, desalination and purification, supporting global sustainability efforts.

“Since its establishment, Suqia UAE, launched by His Highness Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister of the UAE and Ruler of Dubai, has provided clean water to nearly 15 million people in 37 countries worldwide through sustainable development and humanitarian projects. Additionally, Suqia UAE, under the umbrella of the Mohammed bin Rashid Al Maktoum Global Initiatives and through the Mohammed bin Rashid Al Maktoum Global Water Award, continues to motivate innovators and researchers around the world to develop practical and sustainable solutions to address the water scarcity crisis, which remains one of the most prominent humanitarian and development challenges. UN reports indicate that about 2.2 billion people worldwide still lack access to safely managed drinking water services and that around 10% of the global population lives in countries experiencing high or critical water stress,” said Al Tayer.

“I urge universities, research centres, companies, organisations, and innovators worldwide to participate so that, together, we can help provide clean water to communities most in need,” added Al Tayer.

Mohammed Al Shamsi, Acting Executive Director of Suqia UAE, said the award has received hundreds of applications over four cycles, recognising 43 innovators from 26 countries for pioneering, affordable and sustainable water technologies.

Prizes totalling USD 1 million

The award comprises four main categories: the Innovative Projects Award, which includes the Large Projects Award and the Small Projects Award; the Innovative Research and Development Award, which includes the National Institutions Award and the International Institutions Award; the Innovative Individual Award, which includes the Distinguished Researcher Award and the Youth Award; and the Innovative Crisis Solutions Award.

Applications are open until 30 April 2026 via www.mbrwateraward.ae/awards. Inquiries can be sent to award@suqia.ae.

Permalink

https://www.aetoswire.com/en/news/MBRGWA15122025E

Contacts

Shaikha Almheiri , +971552288228

Mohammed Ben Sulayem Re-Elected as President of the FIA

 (BUSINESS WIRE) -- The Fédération Internationale de l’Automobile (FIA), the global governing body for motor sport and the federation for mobility organisations worldwide, today confirms that Mohammed Ben Sulayem has been re-elected as President of the FIA, following the election of his Presidential List by the General Assembly in Tashkent, Republic of Uzbekistan.

President Mohammed Ben Sulayem now begins his second four-year term, having overseen a period of significant renewal and stabilisation for the organisation since his initial election in 2021.

Over the past four years, the FIA has undergone a wide-ranging transformation, improving governance, operations and restoring the financial health of the federation. These changes have strengthened the FIA’s position as the world’s governing body for motorsport and the leading authority on safe, sustainable, and affordable mobility.

Under Mohammed Ben Sulayem’s leadership the FIA has reversed a €-24.0m loss in 2021 to a robust operating result of €4.7m in 2024, the strongest financial result the federation has seen in almost 10 years. Today at the FIA Annual General Assemblies, the FIA announced a 2025 operating result forecast of €4.4m, showing continued momentum and sustained financial improvement. This renewed stability has enabled increased long-term investment in Member Clubs and strategic programmes worldwide.

Underpinning this momentum is wider institutional reform over the last four years, with strengthened budgetary discipline, enhanced external audit processes and modernised governance structures, resulting in greater transparency, accountability and professional standards across the organisation.

In addition to these reforms, the FIA has established a commercial function and strengthened its global institutional identity across both motorsport and mobility, expanding regional development activity, supporting grassroots participation, and deepening engagement with international partners on safety, sustainable mobility and the future of transport.

President Mohammed Ben Sulayem said: “Thank you to all our FIA Members for voting in remarkable numbers and placing your trust in me once again. We have overcome many obstacles but here today, together, we are stronger than ever.

“It is truly an honour to be FIA President, and I am committed to continuing to deliver for the FIA, for motorsport, for mobility, and for our Member Clubs in every region around the world.”

The election was conducted in line with the FIA’s statutes through a robust and transparent voting process, reflecting the democratic foundations of the federation and the collective voice of its global membership.

ENDS

About the FIA:

The Fédération Internationale de l’Automobile (FIA) is the governing body for world motor sport and the federation for mobility organisations globally. It is a non-profit organisation committed to driving innovation and championing safety, sustainability and equality across motor sport and mobility.

Founded in 1904, with offices in Paris, London and Geneva, the FIA brings together 245 Member Organisations across five continents, representing millions of road users, motor sport professionals and volunteers. It develops and enforces regulations for motor sport, including seven FIA World Championships, to ensure worldwide competitions are safe and fair for all.

About Mohammed Ben Sulayem:

Mohammed Ben Sulayem, 64, from United Arab Emirates, is a fourteen-time FIA Middle East Rally Champion, winning 61 international events as a driver between 1983-2002. Prior to his first term as FIA President, of which he is the first non-European to be elected, he was FIA Vice President for Sport and Member of the World Motor Sport Council, a Founding Member of ACTAC, Chair of ACTAC, and Vice President for Automobile Mobility and Tourism.

He has been the President of the FIA since 2021 and founded the United Against Online Abuse Campaign in 2023.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20251212213181/en/

Permalink

https://www.aetoswire.com/en/news/1212202551734

Contacts

For media enquiries, please contact:

Sophia Martin-Pavlou, Director of Corporate Communications – smartin-pavlou@fia.com

Geraldine Sherwin, Director of Presidential and Mobility Communications – gsherwin@fia.com

FIA, Formula 1 Group and All 11 Race Teams Officially Sign the Ninth Concorde Agreement, Securing Strength and Stability for the Sport in Pivotal Five-Year Agreement

 PARIS - 

Multi-year Concorde Governance Agreement signed by the FIA, Formula 1 Group and all 11 teams, securing the World Championship through 2030

Paves the way for a more professionalised sport and represents a new era of collaboration between the FIA and Formula 1 Group

Long-term commitment enhances sporting reliability, global reach and stability for teams, fans and broadcasters

 

(BUSINESS WIRE)--The Fédération Internationale de l'Automobile (FIA), the global governing body for motor sport and the federation for mobility organisations worldwide, and Formula 1 Group, the Commercial Rights Holder, have today announced the signing of the Concorde Governance Agreement, a crucial contract defining the regulatory framework and governance terms of the FIA Formula One World Championship until 2030. This follows the announcement in March that the 2026 Commercial Concorde Agreement had been signed by all the teams and Formula 1 Group. Together, these agreements constitute the ninth Concorde Agreement, representing a major step forward in the professionalisation and global development of the sport.

First introduced in 1981, the Concorde Agreements are designed to promote sporting fairness, technological innovation and operational excellence, and align all key stakeholders around a shared vision for structured governance and continued growth of the sport. Each iteration of the Concorde Agreements has shaped the FIA Formula One World Championship into the global spectacle it is today.

The ninth Concorde Agreement announced today marks the beginning of a new era of collaboration between the FIA and Formula 1 Group, who have worked together to write the next chapter in Formula 1 history, demonstrating mutual respect, transparency and shared purpose between the two organisations. It confirms the participation of all FIA Formula One World Championship teams, including the incoming Cadillac Formula 1 team, through the end of the decade, and provides a stable foundation for the sporting and technical evolution of the sport.

The Concorde Agreement underscores the commitment of the FIA, Formula 1 Group and all teams to continue growing and developing the sport, and to keep driving the momentous expansion it has seen in recent years. The new contract enables the FIA to invest further in improved race regulation, race direction, stewarding and technical expertise for the benefit of the Championship, and means the sport can continue to evolve, providing exciting technological innovation and sporting action for fans, broadcasters and partners, all within a stable and structured regulatory framework. Combined with record viewership growth, a dynamic race calendar, and increasing engagement from younger audiences, the FIA Formula One World Championship enters this next chapter with unprecedented momentum.

Mohammed Ben Sulayem, President of the FIA, said:

“The ninth Concorde Agreement secures the FIA Formula One World Championship’s long-term future and I am proud of the dedication that has been invested in this process. I would like to thank Stefano Domenicali and his team in what has been a strong collaboration, building a framework grounded in fairness, stability, and shared ambition. This agreement allows us to continue modernising our regulatory, technological, and operational capabilities, including supporting our race directors, officials, and the thousands of volunteers whose expertise underpin every race. We are ensuring that Formula 1 remains at the forefront of technological innovation, setting new standards in global sport.”

Stefano Domenicali, President and CEO of Formula 1 Group, said:

“Today is an important day for Formula 1. As we celebrate seventy-five years of this incredible sport, we are proud to write the next chapter in our long and amazing history. This agreement ensures that Formula 1 is in the best possible position to continue to grow around the world. I want to thank the President of the FIA, Mohammed Ben Sulayem and all the teams for the collaboration and determination to achieve the best results for the entire sport in our discussions. We have a huge amount to be proud of, but we also are focussed on the opportunities and exciting potential for Formula 1 in the years ahead.”

The Fédération Internationale de l'Automobile (FIA) is the governing body for world motor sport and the federation for mobility organisations globally. It is a non-profit organisation committed to driving innovation and championing safety, sustainability and equality across motor sport and mobility.

Founded in 1904, with offices in Paris, London and Geneva, the FIA brings together 245 Member Organisations across five continents, representing millions of road users, motor sport professionals and volunteers. It develops and enforces regulations for motor sport, including seven FIA World Championships, to ensure worldwide competitions are safe and fair for all.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20251212020995/en/

Permalink

https://www.aetoswire.com/en/news/1312202551735

Contacts

For media enquiries please contact:

Jonathan Refoy, FIA Chief Communications Officer – jrefoy@fia.com

Cameron Kelleher, FIA Sport Communications Senior Director | Head of Formula 1 Communications – ckelleher@fia.com

Sophia Martin-Pavlou, FIA Corporate Communications Director – smartin-pavlou@fia.com

Kioxia Develops Core Technology that Will Allow the Practical Implementation of High-density, Low-power 3D DRAM

 TOKYO - Friday, 12. December 2025 AETOSWire Print 

Showcase the technology of highly stackable oxide-semiconductor channel transistors

(BUSINESS WIRE)--Kioxia Corporation, a world leader in memory solutions, today announced the development of highly stackable oxide-semiconductor channel transistors that will enable the practical implementation of high-density, low-power 3D DRAM. This technology was presented at the IEEE International Electron Devices Meeting (IEDM) held in San Francisco, USA, on December 10, and has the potential to reduce power consumption across a wide range of applications, including AI servers and IoT components.

In the era of AI, there is growing demand for DRAM with larger capacity and lower power consumption that can process large amounts of data. Traditional DRAM technology is reaching the physical limits of memory cell size scaling, prompting research into the 3D stacking of memory cells to provide additional capacity. The use of single-crystal silicon as the channel material for transistors in stacked memory cells, as is the case with conventional DRAM, drives up manufacturing costs, and the power required to refresh the memory cells increases proportionally to the memory capacity.

At last year’s IEDM, we announced the development of Oxide-Semiconductor Channel Transistor DRAM (OCTRAM) technology that uses vertical transistors made of oxide-semiconductors. In this year's presentation, we showcased technology of highly stackable oxide-semiconductor channel transistors allowing 3D stacking of OCTRAM, verifying the operation of transistors stacked in eight layers.

This new technology stacks mature silicon-oxide and silicon-nitride films and replaces the silicon-nitride region with an oxide-semiconductor (InGaZnO) to simultaneously form vertical layers of horizontally-stacked transistors. We have also introduced a novel 3D memory cell structure capable of scaling the vertical pitch. These manufacturing processes and structures are expected to overcome the cost challenges of achieving 3D stacking of memory cells.

Additionally, it is expected that the refresh power can be reduced thanks to the low off-current characteristics of oxide-semiconductors. We have demonstrated high on-current (more than 30μA) and ultra-low off-current (less than 1aA, 10^-18A) capabilities for the horizontal transistors formed by the replacement process. Moreover, we have successfully fabricated an 8-layer stack of horizontal transistors and confirmed the successful operation of the transistors within that structure.

At Kioxia Corporation we will continue our research and development of this technology in order to realize the deployment of 3D DRAM in real-world applications.

* This announcement has been prepared to provide information on our business and does not constitute or form part of an offer or invitation to sell or a solicitation of an offer to buy or subscribe for or otherwise acquire any securities in any jurisdiction or an inducement to engage in investment activity nor shall it form the basis of or be relied on in connection with any contract thereof.

* Information in this document, including product prices and specifications, content of services and contact information, is correct on the date of the announcement but is subject to change without prior notice.

About Kioxia

Kioxia is a world leader in memory solutions, dedicated to the development, production and sale of flash memory and solid-state drives (SSDs). In April 2017, its predecessor Toshiba Memory was spun off from Toshiba Corporation, the company that invented NAND flash memory in 1987. Kioxia is committed to uplifting the world with “memory” by offering products, services and systems that create choice for customers and memory-based value for society. Kioxia's innovative 3D flash memory technology, BiCS FLASH™, is shaping the future of storage in high-density applications, including advanced smartphones, PCs, automotive systems, data centers and generative AI systems.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20251211322385/en/

Permalink

https://www.aetoswire.com/en/news/54375254

Contacts

Contacts

Kota Yamaji

Public Relations

Kioxia Corporation

+81-3-6478-2319

kioxia-hd-pr@kioxia.com

Saudi Arabia’s EIF and Legends Global Score Big Joint Venture Announcement

  Riyadh, Saudi Arabia - Wednesday, 10. December 2025 AETOSWire Print 

Saudi Arabia’s Events Investment Fund (EIF) and Legends Global have announced a joint venture to support the Kingdom’s vision and investment in its fast-growing venue industry.

 

This partnership will become the venue operator for venue projects within the Kingdom of Saudi Arabia for exhibition and convention centres and entertainment venues to host world-class events in the culture, entertainment, tourism and indoor sports sectors.

 

This incredible investment supports the goals of Vision 2030 and represents a new era in the design, development and operation of world-class venues across the Kingdom of Saudi Arabia.

 

Under the joint venture, Legends Global will deliver management services exclusively for the EIF-developed venues as they are delivered in Saudi Arabia.

 

The signing ceremony took place today at the Development Finance Conference MOMENTUM 2025 in Riyadh, Saudi Arabia. The first venue to be delivered under the agreement will be an Olympic standard shooting range in Riyadh, followed by a business convention and exhibition centre and an arena in Riyadh.

 

Wahdan Suliman Alkadi, Chief Executive Officer at EIF, said: “This joint venture with Legends Global is a defining moment for Saudi Arabia’s events sector. By combining EIF’s vision with Legends’ world-class operational expertise, we are building the foundation for a sustainable, globally competitive industry. This partnership will not only set new standards for venue quality and guest experience but will also unlock new opportunities for local talent and drive economic growth through innovation and international best practices.”

 

Dan Levy, Chief Executive Officer at Legends Global, said: “The visionary leadership of HRH Prince Mohammed bin Salman Al Saud, Crown Prince of Saudi Arabia is being realised and I want to thank Wahdan Suliman Alkadi and the EIF for their partnership with Legends Global. We are proud to collaborate on this once-in-a-generation opportunity to help shape the future of Saudi Arabia's events industry. Drawing on decades of experience, we will deliver a bold vision that benefits citizens and residents while attracting millions of visitors. Together, we are creating destinations, activating communities and advancing Vision 2030 through a portfolio of iconic spaces that serve as catalysts for economic diversification, tourism growth and cultural exchange.” 

 

President and Chief Executive, Asia Pacific and Middle East, for Legends Global, Harvey Lister AM, added: “There is real value in working closely together and blending local heritage with global expertise to help create a network of exceptional venues, innovative management and inclusive experiences. Our global network will help create a thriving ecosystem that attracts international artists, sports and event content to feature alongside local event and festival organisers. Together, we are redefining how people gather, connect and experience entertainment, business and culture.”

Permalink

https://www.aetoswire.com/en/news/1012202551620

Contacts

Catherine Michael, cmichael@legendsglobal.com

Ahmed Nooraldeen, anooraldeen@eif.gov.sa

Galderma Announces First Patient Enrollment in Study to Assess Nemolizumab in Adults With Chronic Pruritus of Unknown Origin

ZUG, Switzerland - Thursday, 11. December 2025 AETOSWire 

Chronic Pruritus of Unknown Origin (CPUO) is characterized by a persistent, chronic itch with an unknown cause and is associated with very high burden of disease due to severe itch, sleep deprivation and mental distress1

Galderma’s phase II study builds on emerging research that reinforces the role of IL-31 – a neuroimmune cytokine that is involved in driving itch – in CPUO1

Nemolizumab is a monoclonal antibody that specifically targets the IL-31 receptor alpha, inhibiting the signaling of IL-312

It is approved by multiple regulatory authorities for the treatment of moderate-to-severe atopic dermatitis and prurigo nodularis – conditions in which IL-31 plays a key role in driving itch, inflammation, epidermal dysregulation, and, in prurigo nodularis, fibrosis2-6

 

(BUSINESS WIRE)--Galderma (SIX: GALD), the pure-play dermatology category leader, today announced the first patient enrollment for its phase II study investigating the efficacy and safety of nemolizumab in treating patients living with Chronic Pruritus of Unknown Origin (CPUO). The first patient of the trial – which is taking place in the United States – was enrolled at Dr. Vlada Groysman’s site in Birmingham, Alabama.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251210261871/en/

CPUO is an underdiagnosed condition defined as itch lasting for more than six weeks without an identified cause.1 It is a common condition and prevalent in nearly 30% of the elderly in certain populations, but despite its debilitating impact – with effects on sleep, mental health, and overall quality of life – there are currently no approved treatments.1,7

Nemolizumab is a monoclonal antibody that specifically targets the IL-31 receptor alpha, inhibiting the signaling of IL-31, a neuroimmune cytokine that plays a key role in CPUO by driving itch, its main symptom.1-4 This randomized, double-blind, placebo-controlled phase II study will determine the therapeutic potential of nemolizumab in adults with CPUO, to support progression to late-stage development.8

 

“We’re excited to launch this study exploring nemolizumab’s potential in patients with CPUO, many of whom have struggled for years without effective treatment options. Nemolizumab has shown outstanding efficacy in prurigo nodularis – a condition that shares important clinical and mechanistic features with CPUO – through its targeted inhibition of IL-31 signaling. With recent research further reinforcing IL-31 as a key driver of itch in CPUO, we’re hopeful that nemolizumab could offer meaningful relief to patients with this condition.”

DOCTOR SHAWN KWATRA, M.D.

LEAD INVESTIGATOR, CHRONIC PRURITUS OF UNKNOWN ORIGIN PHASE II STUDY

 

New data provides a better understanding of the key drivers of CPUO, underscoring the role of IL-31

Galderma’s study builds on a recent investigation into the causes of inflammation in CPUO, which uncovered critical insights into its complex inflammatory profile. The research – presented at the Society of Investigative Dermatology annual meeting in San Diego in May 2025 – found a significant increase in IL-31-producing CD4+ T cells in CPUO patients, reinforcing IL-31 as a key driver of the disease.9 These results open the door to targeted therapies that address the root causes of CPUO, a disease with significant unmet needs that currently has no approved treatment options.1,9

 

“The first patient enrollment in this study marks an important milestone in our commitment to advancing dermatology for every skin story – especially in areas of high unmet need. CPUO is a deeply distressing condition for patients, and the absence of approved treatments has left many without options. With nemolizumab’s targeted mechanism of action and promising results in related conditions, we’re hopeful this study will pave the way for a new therapeutic approach for those living with CPUO.”

BALDO SCASSELLATI SFORZOLINI, M.D., PH.D.

GLOBAL HEAD OF R&D

GALDERMA

 

More information about the study is available on the clinicaltrials.gov website.

About nemolizumab

Nemolizumab was approved in August 2024 by the United States Food and Drug Administration (U.S. FDA) for the treatment of adults with prurigo nodularis.3 In December 2024, it was also approved by the U.S. FDA for the treatment of patients 12 years and older with moderate-to-severe atopic dermatitis, in combination with topical corticosteroids and/or calcineurin inhibitors when the disease is not adequately controlled with topical prescription therapies.3 To date, nemolizumab is approved for both moderate-to-severe atopic dermatitis and prurigo nodularis by multiple regulatory authorities around the world, including in the European Union, Australia, Singapore, Switzerland and the United Kingdom. Additional regulatory submissions and reviews are ongoing.

Nemolizumab was initially developed by Chugai Pharmaceutical Co., Ltd. In 2016, Galderma obtained exclusive rights to the development and marketing of nemolizumab worldwide, except in Japan. In Japan, nemolizumab is marketed as Mitchga® and is approved for the treatment of prurigo nodularis, as well as pruritus associated with atopic dermatitis in pediatric, adolescent, and adult patients.10,11

About Galderma

Galderma (SIX: GALD) is the pure-play dermatology category leader, present in approximately 90 countries. We deliver an innovative, science-based portfolio of premium flagship brands and services that span the full spectrum of the fast-growing dermatology market through Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. Since our foundation in 1981, we have dedicated our focus and passion to the human body’s largest organ – the skin – meeting individual consumer and patient needs with superior outcomes in partnership with healthcare professionals. Because we understand that the skin we are in shapes our lives, we are advancing dermatology for every skin story. For more information: www.galderma.com.

References

Teresa J, et al. Therapeutics in chronic pruritus of unknown origin. Itch. 2023;8(1): pe64. doi: 10.1097/itx.0000000000000064

Silverberg JI, et al. Phase 2B randomized study of nemolizumab in adults with moderate-to-severe atopic dermatitis and severe pruritus. J Allergy Clin Immunol. 2020;145(1): 173-182. doi: 10.1016/j.jaci.2019.08.013

Nemluvio® U.S. Prescribing Information. Available online. Accessed October 2025

Nemluvio® European Medicines Agency. Summary of Product Characteristics. Available online. Accessed October 2025

Bewley A, et al. Prurigo Nodularis: A Review of IL-31RA Blockade and Other Potential Treatments. Dermatol Ther (Heidelb). 2022;12(9):2039–2048. doi: 10.1007/s13555- 022-00782-2

Kwatra SG, Misery L, Clibborn C, Steinhoff M. Molecular and cellular mechanisms of itch and pain in atopic dermatitis and implications for novel therapeutics. Clin Transl Immunology. 2022;11(5):e1390. doi: 10.1002/cti2.1390

Andrade E, et al. Interventions for chronic pruritus of unknown origin. CDSR. 2020;1(1): CD013128. doi: 10.1002/14651858.CD013128.pub2

ClinicalTrials.Gov. Proof of Concept Study to Assess the Pharmacokinetics/​Pharmacodynamics of Nemolizumab in Adults With Chronic Pruritus of Unknown Origin (CPUO) (CPUO). Available online. Last accessed October 2025

Gage G, et al. Peripheral blood high-dimension flow cytometry of chronic pruritus of unknown origin reveals il-31 and oncostatin m+ producing circulating blood CD4+ T cells. Abstract 0966. Society for Investigative Dermatology (SID) 2025 Meeting Abstract Supplement. J Invest Dermatol Volume 145 Issue 8 SupplementS1-S266

Chugai Pharmaceutical Co., Ltd. Maruho Obtained Regulatory Approval for Mitchga, the first Antibody Targeting IL-31 for Itching Associated with Atopic Dermatitis. Available online. Accessed October 2025

Chugai Pharmaceutical Co., Ltd. Mitchga Approved for Itching in Pediatric Atopic Dermatitis and Prurigo Nodularis, for its Subcutaneous Injection 30mg Vials. Available online. Accessed October 2025 

 

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20251210261871/en/

Permalink

https://www.aetoswire.com/en/news/1112202551635

Contacts

For further information:

Christian Marcoux, M.Sc.

Chief Communications Officer

christian.marcoux@galderma.com

+41 76 315 26 50

Emil Ivanov

Head of Strategy, Investor Relations, and ESG

emil.ivanov@galderma.com

+41 21 642 78 12

Richard Harbinson

Corporate Communications Director

richard.harbinson@galderma.com

+41 76 210 60 62

Jessica Cohen

Investor Relations and Strategy Director

jessica.cohen@galderma.com

+41 21 642 76 43

Céline Buguet

Franchises and R&D Communications Director

celine.buguet@galderma.com

+41 76 249 90 87